337 related articles for article (PubMed ID: 14982793)
21. Fluconazole and amphotericin B for cryptococcal meningitis.
Clark AB; Lobo BL; Gelfand MS
Ann Pharmacother; 1996 Dec; 30(12):1408-10. PubMed ID: 8968453
[TBL] [Abstract][Full Text] [Related]
22. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
[No Abstract] [Full Text] [Related]
23. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
Khyriem AB; Sujatha S; Parija SC
Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
Lu R; Hollingsworth C; Qiu J; Wang A; Hughes E; Xin X; Konrath KM; Elsegeiny W; Park YD; Atakulu L; Craft JC; Tramont EC; Mannino R; Williamson PR
mBio; 2019 May; 10(3):. PubMed ID: 31138748
[No Abstract] [Full Text] [Related]
25. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS
Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244
[TBL] [Abstract][Full Text] [Related]
26. Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
Shindo K
Drugs Exp Clin Res; 1990; 16(7):327-32. PubMed ID: 1965500
[TBL] [Abstract][Full Text] [Related]
27. Antifungal therapy for treatment of cryptococcal meningitis.
Yao Z; Liao W; Wen H
Chin Med J (Engl); 2000 Feb; 113(2):178-80. PubMed ID: 11775548
[TBL] [Abstract][Full Text] [Related]
28. Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing.
Soares BM; Santos DA; Kohler LM; da Costa César G; de Carvalho IR; dos Anjos Martins M; Cisalpino PS
Rev Iberoam Micol; 2008 Dec; 25(4):242-5. PubMed ID: 19071894
[TBL] [Abstract][Full Text] [Related]
29. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
Molloy SF; Kanyama C; Heyderman RS; Loyse A; Kouanfack C; Chanda D; Mfinanga S; Temfack E; Lakhi S; Lesikari S; Chan AK; Stone N; Kalata N; Karunaharan N; Gaskell K; Peirse M; Ellis J; Chawinga C; Lontsi S; Ndong JG; Bright P; Lupiya D; Chen T; Bradley J; Adams J; van der Horst C; van Oosterhout JJ; Sini V; Mapoure YN; Mwaba P; Bicanic T; Lalloo DG; Wang D; Hosseinipour MC; Lortholary O; Jaffar S; Harrison TS;
N Engl J Med; 2018 Mar; 378(11):1004-1017. PubMed ID: 29539274
[TBL] [Abstract][Full Text] [Related]
30. Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.
Yao ZW; Lu X; Shen C; Lin DF
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1339-44. PubMed ID: 24550039
[TBL] [Abstract][Full Text] [Related]
31. In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans.
Nguyen MH; Barchiesi F; McGough DA; Yu VL; Rinaldi MG
Antimicrob Agents Chemother; 1995 Aug; 39(8):1691-5. PubMed ID: 7486902
[TBL] [Abstract][Full Text] [Related]
32. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
[TBL] [Abstract][Full Text] [Related]
33. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
[TBL] [Abstract][Full Text] [Related]
34. Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.
Merry M; Boulware DR
Clin Infect Dis; 2016 Jun; 62(12):1564-8. PubMed ID: 27009249
[TBL] [Abstract][Full Text] [Related]
35. Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.
Milefchik E; Leal MA; Haubrich R; Bozzette SA; Tilles JG; Leedom JM; McCutchan JA; Larsen RA
Med Mycol; 2008 Jun; 46(4):393-5. PubMed ID: 18415850
[TBL] [Abstract][Full Text] [Related]
36. The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis.
Garvey EP; Sharp AD; Warn PA; Yates CM; Schotzinger RJ
J Antimicrob Chemother; 2018 Oct; 73(10):2815-2822. PubMed ID: 29947783
[TBL] [Abstract][Full Text] [Related]
37. [The efficacy of sequential treatment with amphotericin B-fluorocytosine and fluconazole in cryptococcal meningitis not associated with AIDS].
Pintado García V; Martín Dávila P; Muñoz Labián V; Quereda Rodríguez-Navarro C
Rev Clin Esp; 1999 Jul; 199(7):480. PubMed ID: 10481571
[No Abstract] [Full Text] [Related]
38. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
Perfect JR; Cox GM; Dodge RK; Schell WA
Antimicrob Agents Chemother; 1996 Aug; 40(8):1910-3. PubMed ID: 8843302
[TBL] [Abstract][Full Text] [Related]
39. HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
Vidal JE; de Albuquerque Moraes C; de Siqueira REB; Miranda NFB; Marcusso R; Boulware DR; de Oliveira ACP
Mycopathologia; 2021 Mar; 186(1):93-102. PubMed ID: 33258083
[TBL] [Abstract][Full Text] [Related]
40. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
